hotspot -WSS

hotspot

author：Wikipedia 2025-09-06 08:39:25 - browse：3

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： STAT reporters are Pulitzer Prize finalists for investigative reporting

WSS

Hospitals consider fixing cancer drug shortages on their own

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

IRA could hurt research into orphan drugs for rare diseases

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Acelyrin, a rare IPO success, stumbles in its first big test

leisure time

hotspot

leisure time

Medicare details structure of new drug price negotiation program

Abbott's new stent may help patients with peripheral artery disease

Moonlake's readout produced a cash windfall. Risks remain

Cherokee Nation medical school graduates its first class

Walensky prepares to leave CDC — and Congress — behind

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

23andMe had bad news about my health. I wish a person had delivered it

PEPFAR is under serious threat — and so is global health

George Santos makes 1st court appearance after pleading not guilty to 13 counts

White House touts steps to stem shortages of cancer treatments

focus

Acelyrin, a rare IPO success, stumbles in its first big test

A common UTI test for kids haunts adults as a traumatic 'nightmare'

How housing is health care on Long Island

Diverse clinical trials: Why aren’t we there yet?

The United States must get value

Regeneron agrees to White House price limits on anti

hotspot

Wikipedia

Wikipedia

focus